718610-76-5

Basic information

• Product Name: 2-Imidazolidinone, 1,5-dimethyl-3-[3-[1-(methylsulfonyl)-4-piperidinyl]-1-oxo-2-propenyl]-4- phenyl-, (4R,5S)-
• CAS NO: 718610-76-5
• Molecular Formula: C20H27N3O4S
• Molecular Weight: 405.518
• Mol File: 718610-76-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-Imidazolidinone, 1,5-dimethyl-3-[3-[1-(methylsulfonyl)-4-piperidinyl]-1-oxo-2-propenyl]-4- phenyl-, (4R,5S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Imidazolidinone, 1,5-dimethyl-3-[3-[1-(methylsulfonyl)-4-piperidinyl]-1-oxo-2-propenyl]-4- phenyl-, (4R,5S)-(718610-76-5)
• EPA Substance Registry System: 2-Imidazolidinone, 1,5-dimethyl-3-[3-[1-(methylsulfonyl)-4-piperidinyl]-1-oxo-2-propenyl]-4- phenyl-, (4R,5S)-(718610-76-5)

Safety Data

• Hazardous Substances Data: 718610-76-5(Hazardous Substances Data)

Upstream product

• 92841-65-1 (4R,5S)-1,5-dimethyl-4-phenylimidazolidin-2-one 

Downstream Products

• 718610-77-6 (3R) 3-[3-phenyl-3-(N-methanesulphonylpiperidin-4-yl)propionyl]-(4R,5S)-1,5-dimethyl-4-phenyl-2-imidazolidinone 
• 1359739-11-9 C₂₆H₃₂ClN₃O₄S 
• 1359739-08-4 C₂₇H₃₅N₃O₄S 
• 1359739-04-0 C₃₁H₄₃Cl₂N₃O₅S₂ 
• 1359739-03-9 C₃₁H₄₄ClN₃O₅S₂ 
• 1359739-02-8 C₃₃H₄₉N₃O₅S₂ 
• 872879-86-2 [3H]-AZD₅₆₇₂ 
• 1359739-00-6 C₃₂H₄₇N₃O₅S₂ 
• 1359738-98-9 C₃₂H₄₇N₃O₆S₂ 
• 1359738-97-8 C₃₂H₄₇N₃O₇S₃ 
• 527695-55-2 C₃₁H₄₅N₃O₅S₂ 
• 1359739-21-1 C₁₅H₁₉Cl₂NO₃S 
• 1359739-20-0 C₁₆H₂₀F₃NO₃S 
• 1359739-19-7 C₁₅H₂₀ClNO₃S 

Relevant articles and documents

Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis

Modifications to a series of potent and selective substituted 1-(3,3-diphenylpropyl)-piperidine phenylacetamide CCR5 antagonists were explored with the aim of reducing affinity at the hERG cardiac ion channel. Replacement of one aromatic ring in the diphe

NOVEL PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR CCR5

Compounds of formula (I) wherein R1, R2, R3, R4, A, X, m and n are as defined; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).